Six months versus nine months chemotherapy for tuberculosis of lymph nodes: Final results
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Of 199 patients treated for peripheral lymph node tuberculosis, 157 completed treatment as planned. Fifty received E2H9R9, 56 Z2 H9R9 and 51 Z2H6R6 regimens (E = Ethambutol; H = Isoniazid; R = Rifampicin; Z = pyrazinamide: numbers denote duration of therapy in months). In follow-up from 9 to 30 months, there were no significant differences between the regimens in enlargement of existing nodes, development of new glands or sinuses, in the need for new operative procedures, or in the percentage with measurable nodes at 30 months. Nine patients were felt to have had a clinical relapse (4 E2H9R9; 2 Z2H9R9; 3 Z2H6R6) although this was not confirmed bacteriologically in the five cases where material was sent for culture. These differences were not statistically different. The 6 month Z2H6R6 regimen performs just as well as the 9 month regimens Z2H9R9 and E2H9R9 in patients with fully sensitive organisms, and has the additional benefits of convenience and reduced cost.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The 6-month recommendation is supported by studies that showed no difference between 6 and 9 months of treatment in cure rates (89%-94%) [45, 46] or relapse rates (3%) [47].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [45]
Citations
Cites
Lymph node tuberculosis: A comparison of various methods of treatment
Campbell, I. A., & Dyson, A. J. (1977) · Tubercle · doi:10.1016/0041-3879(77)90041-1 · Cited by 189
Self-citationBritish Thoracic Society (1984) · British Journal of Diseases of the Chest · doi:10.1016/s0007-0971(84)80146-1 · Cited by 134
British Thoracic Society (1984) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(84)90165-7 · Cited by 107
Ocular toxicity from ethambutol.
Citron, K. M., & Thomas, G. (1986) · Thorax · doi:10.1136/thx.41.10.737 · Cited by 105
Short course chemotherapy for tuberculous lymphadenitis in children.
Jawahar, M. S., Sivasubramanian, S., Vijayan, V. K., Ramakrishnan, C. V., Paramasivan, C. N., Selvakumar, V, Paul, S., Tripathy, S. P., & Prabhakar, R. (1990) · BMJ · doi:10.1136/bmj.301.6748.359 · Cited by 64
Six-months versus nine-months chemotherapy for tuberculosis of lymphnodes: preliminary results
British Thoracic Society Research Committee (1992) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80142-3 · Cited by 31
Six months' chemotherapy for lymph node tuberculosis
McCarthy, O. R., & Rudd, R. (1989) · Respiratory Medicine · doi:10.1016/s0954-6111(89)80075-7 · Cited by 19
Ormerod, L. P. (1988) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(88)90068-x · Cited by 7
Self-citation
Cited by
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Nahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., Chaisson, L. H., Chaisson, R. E., Daley, C. L., Grzemska, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw376 · Cited by 1,170
Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998
Joint Tuberculosis Committee of the British Thoracic Society (1998) · Thorax · doi:10.1136/thx.53.7.536 · Cited by 527
Diagnosis and Treatment of Extrapulmonary Tuberculosis
Lee, J. Y. (2015) · Tuberculosis and Respiratory Diseases · doi:10.4046/trd.2015.78.2.47 · Cited by 512
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299
Metadata
- Authors
- Campbell, I. A., Ormerod, L. P., Friend, J. A. R., Jenkins, P. A., & Prescott, R. J.
- Affiliations
- British Thoracic Society (GB)
- Venue
- Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 1993-11
- Volume
- 87
- Issue
- 8
- Pages
- 621-623
- ISSN
- 0954-6111 (ISSN-L)
- OpenAlex
- W2072047817
- Cited by
- 87
- References
- 9
- Citations by year
- 2024: 5 · 2023: 3 · 2022: 2 · 2021: 2 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 4 · 2013: 3 · 2012: 2
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Respiratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- tuberculous lymphadenitis, peripheral lymph node tuberculosis, chemotherapy duration, pyrazinamide, ethambutol, isoniazid, rifampicin, relapse, treatment outcomes, cost reduction
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Antitubercular Agents, Drug Administration Schedule, Drug Therapy, Combination, Ethambutol, Follow-Up Studies, Humans, Isoniazid, Middle Aged, Pyrazinamide, Rifampin, Tuberculosis, Lymph Node
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Six months versus nine months chemotherapy for tuberculosis of lymph nodes: Final results. https://app.cochat.ai/papers/10.1016/s0954-6111(05)80265-3
- The paper
- Campbell, I. A., Ormerod, L. P., Friend, J. A. R., Jenkins, P. A., & Prescott, R. J. (1993). Six months versus nine months chemotherapy for tuberculosis of lymph nodes: Final results. Respiratory Medicine. https://doi.org/10.1016/s0954-6111(05)80265-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.